Invariant NKT cells regulate the CD8 T cell response during Theiler's virus infection

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mars, Lennart T ^a,b,c   Mas, Magali ^a   Beaudoin, Lucie ^a   Bauer, Jan ^d   Leite de Moraes, Maria ^e   Lehuen, Agnès ^a   Bureau, Jean Francois ^f   Liblau, Roland S ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d Medical University of Vienna   (Austria)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CERVICAL LYMPH NODE; CONTROLLED STUDY; ENCEPHALOMYELITIS; GENE EXPRESSION; INVARIANT NATURAL KILLER T CELL; MORTALITY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; SPLEEN; TRANSGENIC MOUSE; VIRUS LOAD;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS; EPITOPES; INFLAMMATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; POLIOMYELITIS; SPLEEN; T-LYMPHOCYTE SUBSETS; THEILOVIRUS;

EID: 84900385540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087717     Document Type: Article

References (66)

1. Billingham RE, Boswell T (1953) Studies on the problem of corneal homografts. Proc R Soc Lond B Biol Sci 141: 392-406.
2. Medawar PB (1948) Immunity to homologous grafted skin. Brit J Exp Path 29: 58-69.
3. Shirai Y (1921) On the transplantation of the rat sarcoma in adult hetergenous animals. Jap Med World 1: 14-15.
4. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845.
5. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318. (Pubitemid 40746128)
6. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752-758. (Pubitemid 43085841)
7. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, et al. (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9: 1512-1519. (Pubitemid 44862659)
8. Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Invest 122: 1164-1171.
9. Becher B, Bechmann I, Greter M (2006) Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med (Berl) 84: 532-543. (Pubitemid 43992845)
10. Martin-Blondel G, Delobel P, Blancher A, Massip P, Marchou B, et al. (2011) Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 134: 928-946.
11. McGavern DB, Kang SS (2011) Illuminating viral infections in the nervous system. Nat Rev Immunol 11: 318-329.
12. Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307: 273-276. (Pubitemid 14128971)
13. Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290-292. (Pubitemid 18061496)
14. Barcia C, Wawrowsky K, Barrett RJ, Liu C, Castro MG, et al. (2008) In vivo polarization of IFN-gamma at Kupfer and non-Kupfer immunological synapses during the clearance of virally infected brain cells. J Immunol 180: 1344-1352.
15. Chevalier G, Suberbielle E, Monnet C, Duplan V, Martin-Blondel G, et al. (2011) Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog 7: e1002393.
16. Liblau RS, Gonzalez-Dunia D, Wiendl H, Zipp F (2013) Neurons as targets for T cells in the nervous system. Trends Neurosci 36: 315-324.
17. Saxena A, Bauer J, Scheikl T, Zappulla J, Audebert M, et al. (2008) Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol 181: 1617-1621.
18. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336. (Pubitemid 46697911)
19. Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, et al. (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci U S A 104: 5977-5982. (Pubitemid 47175644)
20. Speak AO, Salio M, Neville DC, Fontaine J, Priestman DA, et al. (2007) Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci U S A 104: 5971-5976. (Pubitemid 47175643)
21. Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. .Science 306: 1786-1789. Epub 2004 Nov 1711.
22. Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22: 817-890. (Pubitemid 38680443)
23. Chang YJ, Kim HY, Albacker LA, Lee HH, Baumgarth N, et al. (2011) Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 121: 57-69.
24. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986. (Pubitemid 44263912)
25. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, et al. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525. (Pubitemid 40477061)
26. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, 3rd, et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529. (Pubitemid 40477062)
27. Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR (2005) Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 35: 1692-1701. (Pubitemid 40862317)
28. Wingender G, Rogers P, Batzer G, Lee MS, Bai D, et al. (2011) Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med 208: 1151-1162.
29. Brennan PJ, Brigl M, Brenner MB (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13: 101-117.
30. Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, et al. (2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 13: 474-480.
31. Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, et al. (2009) Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 7: e1000228.
32. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609. (Pubitemid 47628833)
33. Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, et al. (2012) Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 18: 1060-1068.
34. Mars LT, Novak J, Liblau RS, Lehuen A (2004) Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol 25: 471-476. (Pubitemid 39490253)
35. Furlan R, Bergami A, Cantarella D, Brambilla E, Taniguchi M, et al. (2003) Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur J Immunol 33: 1830-1838. (Pubitemid 37120854)
36. Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, et al. (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 194: 1789-1799. (Pubitemid 34028658)
37. Mars LT, Araujo L, Kerschen P, Diem S, Bourgeois E, et al. (2009) Invariant NKT cells inhibit development of the Th17 lineage. Proc Natl Acad Sci U S A 106: 6238-6243.
38. Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, et al. (2002) Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol 168: 6007-6011. (Pubitemid 34620014)
39. Miyamoto K, Miyake S, Yamamura T (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534. (Pubitemid 32938752)
40. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, et al. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194: 1801-1811. (Pubitemid 34028659)
41. Brahic M (2002) Theiler's virus infection of the mouse, or: of the importance of studying animal models. Virology 301: 1-5.
42. Brahic M, Bureau JF, Michiels T (2005) The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu Rev Microbiol 59: 279-298. (Pubitemid 41507433)
43. Lipton HL (1975) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 11: 1147-1155.
44. Cui J, Shin T, Kawano T, Sato H, Kondo E, et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626. (Pubitemid 27516281)
45. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, et al. (1998) Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 188: 1831-1839. (Pubitemid 28536770)
46. McAllister A, Tangy F, Aubert C, Brahic M (1989) Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb Pathog 7: 381-388. (Pubitemid 20087920)
47. Michiels T, Dejong V, Rodrigus R, Shaw-Jackson C (1997) Protein 2A is not required for Theiler's virus replication. J Virol 71: 9549-9556. (Pubitemid 27492401)
48. Mars LT, Bauer J, Gross DA, Bucciarelli F, Firat H, et al. (2007) CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol 179: 5090-5098.
49. Levillayer F, Mas M, Levi-Acobas F, Brahic M, Bureau JF (2007) Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases. Genetics 176: 1835-1844. Epub 2007 May 1834.
50. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A (2000) In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 191: 1895-1903. (Pubitemid 30390352)
51. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, et al. (2007) Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 62: 67-80. (Pubitemid 47235282)
52. Brahic M, Haase AT, Cash E (1984) Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A 81: 5445-5448. (Pubitemid 14000504)
53. Kim CH, Johnston B, Butcher EC (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16. (Pubitemid 35177421)
54. Mueller SN, Gebhardt T, Carbone FR, Heath WR (2013) Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 31: 137-161.
55. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, et al. (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J Immunol 171: 2571-2580. (Pubitemid 37025568)
56. Mars LT, Gautron AS, Novak J, Beaudoin L, Diana J, et al. (2008) Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J Immunol 181: 2321-2329.
57. Sun J, Madan R, Karp CL, Braciale TJ (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15: 277-284.
58. Hoftberger R, Aboul-Enein F, Brueck W, Lucchinetti C, Rodriguez M, et al. (2004) Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 14: 43-50. (Pubitemid 38200588)
59. Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 198: 173-181. (Pubitemid 36870197)
60. Kivisakk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, et al. (2003) Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A 100: 8389-8394. (Pubitemid 36842555)
61. Kivisakk P, Tucky B, Wei T, Campbell JJ, Ransohoff RM (2006) Human cerebrospinal fluid contains CD4+ memory T cells expressing gut- or skin-specific trafficking determinants: relevance for immunotherapy. BMC Immunol 7: 14.
62. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, et al. (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10: 514-523.
63. Azoulay-Cayla A, Dethlefs S, Perarnau B, Larsson-Sciard EL, Lemonnier FA, et al. (2000) H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. J Virol 74: 5470-5476. (Pubitemid 30346578)
64. Azoulay-Cayla A, Syan S, Brahic M, Bureau JF (2001) Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J Gen Virol 82: 1043-1047. (Pubitemid 32454604)
65. Fiette L, Aubert C, Brahic M, Rossi CP (1993) Theiler's virus infection of beta 2-microglobulin-deficient mice. J Virol 67: 589-592. (Pubitemid 23003027)
66. Rodriguez M, Dunkel AJ, Thiemann RL, Leibowitz J, Zijlstra M, et al. (1993) Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J Immunol 151: 266-276. (Pubitemid 23206991)